Fri, 11 May 2012 | BUSINESS SALE
Bolton-based healthcare software provider Ascribe has brought in US investment bank William Blair & Company to act as adviser on a potential sale.
The potential sale is to be looked into as part of a strategic review. It is understood that the firm could be sold for a price above £50 million and possibly reaching £80 million.
With its experience of making deals in the healthcare industry William Blair & Company are well placed to encourage a sale of Ascribe to a US trade buyer.
Established in 2004, Ascribe develops software for managing information in hospital environments, including patient administration systems, point of care systems and also offers bespoke solutions.
It has offices in Bolton, Cambridge, Southampton, Sydney, Melbourne and Nairobi.
Ascribe reported sales of £25 million for the year to June 2011, with pre-tax profits of £7 million. The sales figure was partly attributed to its successful purchase of rival healthcare business intelligence data firm 21C early last year.
Private equity firm ECI Partners supported a £32.9 million management buy-out of the firm in 2009. It is expected to make moves to exit its relationship with Ascribe at some point.
Seeking parties interested in the business and assets of a company that operates within the sanitation industry.
Seeking parties interested in the business and assets of a company that operates as aesthetics, wellness and medical clinics.
LEASEHOLD
Presently seeking genuine interest in the business and assets of a company that operates as a recruitment provider within the cleantech sector.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.